Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

ROTY Edition 1 Volume 81: We Have A Launch Date!

2018-02-21 seekingalpha
February continues to be our worst month yet, but I focus on positioning the model account for success based on our current plan. (197-0)

ROTY Edition 1 Volume 80: Adding To Select Positions And Continuing To Manage Risk

2018-02-16 seekingalpha
I remind readers of our biggest loser to date and why risk management has been key to ROTY`s success. (146-0)

ROTY Edition 1 Volume 79: Limited Downside Catalysts Vs. Binary Risk

2018-02-14 seekingalpha
We discuss the difference between binary catalysts and those with limited downside, utilizing two recent examples. (166-3)

ROTY Edition 1 Volume 78: Simplify Your Decision-Making And Stick To Guidelines

2018-02-13 seekingalpha
As always, readers are encouraged to do their own due diligence, manage risk appropriately, and avoid blindly following. (313-2)

ROTY Edition 1 Volume 77: Market Turmoil Continues - How To React

2018-02-09 seekingalpha
Recent market volatility is addressed and we discuss in depth how to react while sticking to one´s plan. (192-1)

NuCana: Buy The Dip

2018-02-06 seekingalpha
Initial data from the ABC-08 study evaluating Acelarin in combination with cisplatin in patients with front-line advanced biliary tract cancer was quite promising. (0-1)

Your Daily Pharma Scoop: Omeros' OMS721, Celgene To Acquire Juno, BioCryst And Idera To Merge

2018-01-23 seekingalpha
Omeros’ OMS721 got a positive opinion from EMA’s COMP for an orphan drug designation in Europe. (416-5)